Assessing Choice in the Employer Setting (ACES) Study - MA181
Study identifier:MI-MA-181
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Assessing Choice in the Employer Setting (ACES Study): An Observational Study to Assess the Impact of Offering Intranasal Vaccine on Influenza Vaccination Rates in the Employer Setting
Medical condition
Healthy
Phase
-
Healthy volunteers
Yes
Study drug
-
Sex
All
Actual Enrollment
4411
Study type
Observational
Age
18 Years +
Date
Study Start Date: 01 Sept 2008
Primary Completion Date: 01 Nov 2008
Study Completion Date: 01 Dec 2008
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Oct 2013 by MedImmune LLC
Sponsors
MedImmune LLC
Collaborators
Passport Health, University of Pittsburgh
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| Arm A (Control) A control arm of usual care offering TIV with baseline advertisement | Biological/Vaccine: Control - Usual care offering TIV only with baseline advertisement A control arm of usual care offering TIV with baseline advertisement |
| Arm B (Choice) An intervention arm offering choice of TIV or FluMist with baseline advertisement, including advertisement to highlight the availability of FluMist | Biological/Vaccine: Choice of TIV or FluMist with baseline advertisement An intervention arm offering choice of TIV or FluMist with baseline advertisement, including advertisement to highlight the availability of FluMist |
| Arm C (Choice Plus) An intervention arm offering choice of TIV or FluMist with enhanced advertisement and additional incentives for receiving an influenza vaccination | Other: Choice of TIV or FluMist with enhanced advertisement and incentives An intervention arm offering choice of TIV or FluMist with enhanced advertisement and additional incentives for receiving an influenza vaccination |
Contacts
Investigators
Principal Investigator
Seth Toback
MedImmune LLC
